Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva, Allergan, Mylan Rally Following Sell-Off On DOJ Antitrust Probe | Stock News & Stock Market Analysis - IBD
New York files insurance fraud charges against opioid makers Teva, Allergan - CNA
Israel's Teva to buy Allergan Generics for $40.5bn - Pharmaceutical Technology
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | FiercePharma
Teva, Allergan to face NY charges over role in opioid crisis (NYSE:TEVA) | Seeking Alpha
United States Teva Pharmaceutical Industries Pharmaceutical industry Generic drug Allergan, pharma, blue, angle, company png | PNGWing
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
以色列藥廠Teva砸巨資併購Allergan學名藥部門- 自由財經
Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical Industry Company NYSE:TEVA, PNG, 1248x682px, Teva Pharmaceutical
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
Allergan completes divestiture of global generics business to Teva
Teva to Buy Allergan's Generic-Drug Unit
With Allergan deal sealed, Teva turns its attention to branded M&A | Fierce Pharma
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva lone New York defendant after Allergan opioid settlement - Globes
NY charges Teva, Allergan with fraud over opioids - www.israelhayom.com
Teva investors fret over $41bn generic drugs deal | Financial Times
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Cipla, Glenmark in race for hived-off Teva-Allergan generics in US - The Economic Times
Teva to Buy Allergan Generic Drug Business for $40.5 Billion
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
Teva to switch generics focus to Allergan | Pharmafile
Israel's largest company acquisition: Teva buys Allergan Generics for $40.5 billion, new stage in Israeli business? | EIPA
Allergan to acquire Naurex; divests generics business to Teva
